|
Re: New article from EHJ
|
8
|
Resverlogix Corp.
|
Jan 30, 2018 09:51AM
|
|
Re: New article from EHJ
|
1
|
Resverlogix Corp.
|
Jan 30, 2018 11:04AM
|
|
Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension
|
2
|
Resverlogix Corp.
|
Jun 05, 2019 02:06PM
|
|
Re: New Apabetalone Clinical Trial for Pulmonary Arterial Hypertension
|
4
|
Resverlogix Corp.
|
May 02, 2019 10:48PM
|
|
Re: New analyst?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 26, 2020 12:24PM
|
|
Re: New Alkaline Phosphate publication from Dr. Kalantar-Zadeh
|
3
|
Resverlogix Corp.
|
Nov 17, 2019 12:36PM
|
|
Re: New Alkaline Phosphate publication from Dr. Kalantar-Zadeh
|
6
|
Resverlogix Corp.
|
Nov 17, 2019 01:13PM
|
|
Re: Never heard of them
|
3
|
BIOASIS TECHNOLOGIES INC
|
Sep 18, 2016 03:16PM
|
|
Re: Never heard of them
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 19, 2016 04:18PM
|
|
Re: need more time, money & partners - FDA response may take until spring - pre market bid/ask..
|
9
|
Resverlogix Corp.
|
Dec 06, 2019 11:20AM
|
|
Re: Need An Explanation
|
2
|
Zenith Epigenetics
|
May 17, 2016 11:20AM
|
|
Re: Near Final Draft of Checklist for Management - A Few More Spelling changes
|
2
|
Resverlogix Corp.
|
Jul 27, 2016 12:32PM
|
|
Re: Near Final Draft of Checklist for Management - A Few More Spelling changes
|
2
|
Resverlogix Corp.
|
Jul 27, 2016 04:18PM
|
|
Re: Near Final Draft of Checklist for Management - A Few More Spelling changes
|
1
|
Resverlogix Corp.
|
Jul 28, 2016 08:59AM
|
|
Re: Naz listing?
|
6
|
Resverlogix Corp.
|
Apr 20, 2019 11:13AM
|
|
Re: Naz listing requirements....
|
5
|
Resverlogix Corp.
|
Sep 06, 2018 10:48AM
|
|
Re: Naz listing requirements....
|
4
|
Resverlogix Corp.
|
Sep 06, 2018 02:01PM
|
|
Re: National Kidney Foundation -Abstract: BOM
|
3
|
Resverlogix Corp.
|
Mar 30, 2020 09:51PM
|
|
Re: NASH is a $35 Billion US/year market
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 12:24PM
|
|
Re: NASH is a $35 Billion US/year market
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 09:22PM
|
